Earth Science Tech (OTCQB: ETST), a healthcare, pharmacy, and telemedicine holding company, has uplisted to the OTCQB Venture Market as of Sept. 17, 2026. This move marks a significant milestone in the company's fiscal 2027 growth strategy and follows a strong first quarter, with revenue increasing 3% to $9.0 million and net income rising 57% to $715,697. The uplisting is expected to enhance the company's visibility and credibility among investors, potentially leading to increased liquidity and a broader shareholder base.
The company also completed two strategic acquisitions: Meduvo LLC, a compounding pharmacy, and Zoolzy LLC, a pharmaceutical distributor. These acquisitions expand Earth Science Tech's opportunities in human therapeutics and animal health, aligning with its goal to build a vertically integrated healthcare platform. As a result, the company is better positioned to capture growth in the healthcare and wellness sectors, which could drive future revenue and earnings.
At its Aug. 31 annual shareholder meeting, investors approved several measures supporting potential future uplisting to the Nasdaq or NYSE, the planned retirement of the dual-class voting structure, and a new non-dilutive executive compensation framework. These governance changes are designed to improve operational efficiency, enhance corporate governance, and align management interests with shareholders, which could make the company more attractive to institutional investors.
The uplisting to OTCQB and the acquisitions are part of Earth Science Tech's broader strategy to strengthen its business portfolio and position itself for continued growth. For more details, see the full article at https://ibn.fm/hrUOF. Earth Science Tech operates as a diversified holding company focused on the health and wellness sector, with a principal strategy to build a vertically integrated healthcare platform that combines compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment. The company's healthcare operations are supported by investments in real estate and asset management activities and a consumer products business. To learn more, visit www.EarthScienceTech.com. The latest news and updates relating to ETST are available in the company's newsroom at https://ibn.fm/ETST.
This news is important for investors and the healthcare industry because it demonstrates Earth Science Tech's ability to execute on its growth strategy despite broader market challenges. The uplisting to OTCQB could lead to increased analyst coverage and institutional interest, while the acquisitions of Meduvo and Zoolzy position the company to capitalize on trends in personalized medicine and animal health. Moreover, the governance changes, including the retirement of the dual-class voting structure, may appeal to investors who prioritize shareholder rights. As the company continues to integrate its acquisitions and improve operational efficiency, it could serve as a model for other small-cap healthcare companies seeking to scale and uplist to major exchanges.
BioMedWire, a specialized communications platform for the biotechnology, biomedical sciences, and life sciences sectors, provided the original press release. BioMedWire is part of the Dynamic Brand Portfolio at IBN, which offers services including access to a vast network of wire solutions via InvestorWire, article and editorial syndication to 5,000+ outlets, enhanced press release enhancement, social media distribution, and tailored corporate communications solutions. For more information, visit BioMedWire.
